Hyperinvasive Approach in Cardiac Arrest

Sponsor
Charles University, Czech Republic (Other)
Overall Status
Terminated
CT.gov ID
NCT01511666
Collaborator
(none)
256
1
2
91.8
2.8

Study Details

Study Description

Brief Summary

Prague out-of Hospital Cardiac Arrest (OHCA) study is a prospective randomized multicenter clinical study comparing use of prehospital intraarrest hypothermia, mechanical chest compression device, extracorporeal life support (ECLS) and early invasive investigation and treatment (coronary angiography/percutaneous coronary intervention [PCI]; pulmonary angiography/percutaneous embolectomy; aortography) in all patients with OHCA of presumed cardiac origin compared to standard of care. It is hypothesized, that above stated "hyperinvasive" approach might improve outcome of out-of hospital cardiac arrest victims.

Condition or Disease Intervention/Treatment Phase
  • Device: Prehospital mechanical compressions, intraarrest cooling and in hospital ECLS
  • Other: Standard care
N/A

Detailed Description

Background: Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent non-randomized study of ECLS (extracorporeal life support) in OHCA suggested further prospective multicenter studies to define population with OHCA that would benefit from ECLS.

Aim: to perform a prospective randomized multicenter clinical study comparing use of prehospital intraarrest hypothermia, mechanical chest compression device, ECLS and early invasive investigation and treatment (coronary angiography/percutaneous coronary intervention [PCI]; pulmonary angiography/percutaneous embolectomy; aortography) in all patients with OHCA of presumed cardiac origin compared to standard of care.

Planned intervention: patients with witnessed OHCA without ROSC (return of spontaneous circulation) after a minimum of 5 minutes of ACLS by emergency medical service (EMS) team will be after fulfilling of inclusion/exclusion criteria for the study randomized in a 1:1 design to standard vs. hyperinvasive arm. Patients in standard arm will be further managed as per recent guidelines. In hyperinvasive arm, mechanical compression device together with intranasal cooling will be immediately instituted and patients will be transferred to cardiac center directly to cathlab under ongoing CPR. After admission to cathlab, overall status, ROSC and ECLS inclusion/exclusion criteria will be evaluated and in case of no contraindications to ECLS and no ROSC or ROSC with shock, veno-arterial ECLS will be started as soon as possible, not later than 60 minutes after cardiac arrest onset. After ECLS institution, mild hypothermia will be continued by means of ECLS cooling and immediate invasive investigation will be performed in all patients.

Standard postresuscitation care will follow.

Study Design

Study Type:
Interventional
Actual Enrollment :
256 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Hyperinvasive Approach to out-of Hospital Cardiac Arrest Using Mechanical Chest Compression Device, Prehospital Intraarrest Cooling, Extracorporeal Life Support and Early Invasive Assessment Compared to Standard of Care. A Randomized Parallel Groups Comparative Study. "Prague OHCA Study"
Actual Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Oct 25, 2020
Actual Study Completion Date :
Oct 25, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hyperinvasive arm

Hyperinvasive arm encompasses immediate institution of a mechanical chest compression device (LUCAS) and pre-hospital intraarrest cooling by Rhino-Chill device. Immediately after institution of these two devices the patients will be directly transferred to cardiac center cathlab under continuous CPR. The use of drugs and further defibrillations are on a discretion of the emergency physician. After admission to cathlab, overall status, ROSC presence and ECLS inclusion/exclusion criteria will be evaluated.

Device: Prehospital mechanical compressions, intraarrest cooling and in hospital ECLS
ECLS states for extracorporeal life support.
Other Names:
  • LUCAS
  • Rhinochill
  • ECLS
  • Active Comparator: Standard arm

    Patients in standard arm will be further managed as per recent ERC guidelines, ie. continued ACLS. The use of drugs and further defibrillations are on a discretion of the emergency physician. If ROSC is attained, patients will be transferred to the same hospital to one of intensive care units, coronary angiography/PCI will be performed only if indicated according to routine practice and mild therapeutic hypothermia will be instituted as soon as possible as per recent guidelines recommendation.

    Other: Standard care
    Standard care as per recent guidelines will be provided.

    Outcome Measures

    Primary Outcome Measures

    1. Composite endpoint of survival with good neurological outcome (CPC 1-2). [6 months]

    Secondary Outcome Measures

    1. Neurological recovery [30 days]

      Neurological recovery will be defined as no or minimal neurological impairment (CPC 1 or 2) at any timepoint within first 30 days after initial cardiac arrest.

    2. Cardiac recovery [30 days]

      Cardiac recovery will be assessed by the clinical status of hemodynamic stability defined as no need for pharmacological or mechanical cardiac support. Systolic function will be measured by echocardiography .

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • minimum of 18 and maximum of 65 years

    • witnessed out-of-hospital cardiac arrest of presumed cardiac cause

    • minimum of 5 minutes of ACLS performed by emergency medical service team without sustained ROSC

    • unconsciousness (Glasgow Coma Score < 8)

    • ECMO team and bed-capacity in cardiac center available.

    Exclusion Criteria:
    • OHCA of presumed non-cardiac cause

    • unwitnessed collapse

    • pregnancy

    • sustained ROSC within 5 minutes of ACLS performed by EMS team

    • conscious patient

    • known bleeding diathesis or suspected or confirmed acute or recent intracranial bleeding

    • suspected or confirmed acute stroke

    • known severe chronic organ dysfunction or other limitations in therapy

    • "do not resuscitate" order or other circumstances making 180 day survival unlikely

    • known pre-arrest cerebral performance category CPC ≥ 3.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 General Teaching Hospital Prague Czechia 128 02

    Sponsors and Collaborators

    • Charles University, Czech Republic

    Investigators

    • Principal Investigator: Jan Belohlavek, General University Hospital

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Jan Belohlavek, Jan Belohlavek, MD, PhD., Consultant in Cardiology and Critical Care, Charles University, Czech Republic
    ClinicalTrials.gov Identifier:
    NCT01511666
    Other Study ID Numbers:
    • Prague OHCA study
    First Posted:
    Jan 19, 2012
    Last Update Posted:
    Mar 15, 2021
    Last Verified:
    Mar 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jan Belohlavek, Jan Belohlavek, MD, PhD., Consultant in Cardiology and Critical Care, Charles University, Czech Republic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 15, 2021